A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Clinical trial NCT05576077 · TERMINATED

Trial details

NCT number: NCT05576077
Sponsor: Turnstone Biologics, Corp.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Uveal Melanoma Cutaneous Melanoma Non-Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2023-01-17
Primary completion: 2025-02-04
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.